H B Fuller Company (FUL)

Corkrean John J 🟢 acquired 292.1K shares (14 derivative) of FULLER H B CO (FUL) at $77.72 ($15.9M) Transaction Date: Aug 29, 2025 | Filing ID: 007647

Biogen Inc (BIIB)

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status